Imvax, Inc.

While many emerging immunotherapies require complex manufacturing procedures that can take weeks, Imvax’s #Goldspire platform enables rapid tissue processing. At our facility in Philadelphia, we can complete patient tumor tissue processing and product preparation in less than 24 hours, allowing for implantation into the patient the following day. Learn more about the many advantages of Goldspire® here: https://bit.ly/3Y7GshO #braincancer #cancerresearch #glioblastoma #immunooncology

This month, we attended #EANO2024 to present blinded safety data from our ongoing Phase 2b study of IGV-001 in patients with newly diagnosed glioblastoma. We also sponsored a corporate symposium where we provided an overview of our Goldspire® platform for the treatment of #solidtumors and reviewed the Phase 1 and Phase 2 data of IGV-001 in #glioblastoma.  A special thanks to SOMA SENGUPTA, MD, PhD, MBA, FRCP, ELUM, FAAN, FANA, and Simon Hanft, MD for their participation in the symposium.   #cancerresearch #Goldspire #IGV001 #GBM

#ICYMI: We recently published preclinical research supporting the broader applicability of our #Goldspire platform for the treatment of solid tumors.    Highlights:  🔹 Tumor-specific products prepared with the Goldspire® platform enabled durable systemic immunity in multiple murine #cancer models  🔹 Mice receiving #glioblastoma or melanoma products + anti-PD1 mAb had significantly longer survival and durable tumor control vs. controls 🔹 Patient endometrial product prepared with the Goldspire® platform induced dendritic and T cell activation and memory phenotypes in co-cultures with matched blood cells   Read the full paper here: https://bit.ly/3UnARkK   AACR Journals

The #braintumor community of Greater Philadelphia came together on October 13th at the Race for Hope to raise awareness to support the needs of patients and their families. We were honored to sponsor and join in the race.    Thank you to our partner, the National Brain Tumor Society, for hosting this great event.    #braincancer #cancerresearch #glioblastoma

It was a pleasure to be on the ground in Houston last week for the 2024 Congress of Neurological Surgeons (CNS) Annual Meeting to compare insights on the future of #neurosurgery with fellow industry leaders. #2024CNS

This summer we’ve had the privilege of sponsoring and participating in several 5k races across the country – including on Long Island and in Houston. We’re proud to work closely with the National Brain Tumor Society and the American Brain Tumor Association to help raise awareness and support the needs of patients with #braintumors. #braincancer #cancerresearch #glioblastoma

#DYK estimates show that cancer will be the leading cause of death in coming years? Brain and other nervous system cancers account for ~3.1% of all cancer deaths in the U.S. and can be among the most difficult to treat. On #WorldCancerResearchDay, join us in recognizing the important work being done to prevent and treat #cancer. Here at Imvax, our team is dedicated to developing a unique approach to personalized cancer #immunotherapy. Hear from Jenny Zilberberg, M.S., Ph.D., Imvax's Head of Research, on what World Cancer Research Day means to her. #braincancer #cancerresearch

#DYK estimates show that cancer will be the leading cause of death in coming years? Brain and other nervous system cancers account for ~3.1% of all cancer deaths in the U.S. and can be among the most difficult to treat. On #WorldCancerResearchDay, join us in recognizing the important work being done to prevent and treat #cancer. Here at Imvax, our team is dedicated to developing a unique approach to personalized cancer #immunotherapy. Hear from Jenny Zilberberg, M.S., Ph.D., Imvax's Head of Research, on what World Cancer Research Day means to her. #braincancer #cancerresearch

We recently attended the American Brain Tumor Association's 2024 National Conference where we saw some familiar faces, including Johnathan Gingras from the Joel A. Gingras Memorial Foundation.   We appreciate the opportunity to engage with and learn from those who are impacted by #braincancer.   Imvax is a proud partner of both the ABTA and the JAG Fund, two inspiring organizations working to provide funding, advocacy and support for patients and their families.   #BrainTumorAwareness #BrainCancer #glioblastoma